Humacyte Inc (HUMA) current stock price is $2.21. During the last trading session, the stock soared, reaching $25.0 after opening at $2.21. The stock’s lowest point was $3.0 before it closed at $2.31.
Humacyte Inc’s stock has had a tumultuous market performance.
52-week price history of HUMA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Humacyte Inc’s current trading price is -74.65% away from its 52-week high, while its distance from the 52-week low is 92.17%. The stock’s price range for this period has remained between $1.15 and $8.72. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.06 million for the day, which was noticeably lower compared to the shares’ average daily volume of 4.27 million over the last three months.
Financial Performance and Market Capitalization
Humacyte Inc (HUMA) has experienced a quarterly rise of 79.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 342.81M and boasts a workforce of 220 employees.
Analysts’ Ratings For Humacyte Inc
As of right now, 4 analysts are rating Humacyte Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.14, with a change in price of -0.56. Similarly, Humacyte Inc recorded 4,464,292 in trading volume during the last 100 days, posting a change of -20.22%.
HUMA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for HUMA stands at 2.28. Similarly, the long-term debt-to-equity ratio is also 2.15.
HUMA Stock Stochastic Average
As of today, the raw stochastic average of Humacyte Inc over the past 50 days is 15.29%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 10.00%. Additionally, the Stochastic %K and %D values for the company were 13.08% and 17.72%, respectively, over the past 20 days.
HUMA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -73.21%. However, over the last six months, the performance has been stronger by -49.43%. The price of HUMA decreased -14.01% over the last 30 days. And in the last five days, it has fallen by -9.05%.
